Introduction to RMG Performance Qualification
A RMG Performance Qualification is an important piece of equipment used in pharmaceutical manufacturing, particularly during wet granulation of oral solid dosage formulations. Because the equipment directly influences mixing, wet mass formation, granule development, and subsequent processing, its performance should be demonstrated and documented before routine use.
Performance Qualification (PQ) provides documented evidence that the RMG can consistently perform its intended functions within the established operating range and under defined process conditions.
The uploaded source describes an RMG qualification protocol covering equipment operation, qualification responsibilities, prerequisites, placebo and product-based performance evaluation, sampling, acceptance criteria, deviations, change control, corrective actions, and final reporting.
WHO guidance also emphasizes that qualification and validation should be performed against predetermined protocols and that the results should be appropriately documented. Qualification normally precedes process validation and forms part of the overall lifecycle approach to maintaining a qualified state.
After RMG material is dried in FBP. Check here full Qualification procedure for FBP
What Is RMG Performance Qualification?
RMG Performance Qualification is a documented exercise used to demonstrate that a qualified Rapid Mixer Granulator consistently performs its intended manufacturing function under specified operating conditions.
The objective is not simply to confirm that the machine starts, stops, mixes, or responds to controls. PQ should provide evidence that the equipment performs adequately when used with the intended process or a scientifically justified challenge, and that relevant product and process characteristics remain within predefined requirements.
PQ and the Process Validation Procedure are likely same but different in some sampling location.
RMG operating principle
A typical RMG contains a mixing bowl, impeller and chopper. The impeller promotes mixing of the powder mass, while the chopper assists in breaking down or controlling agglomerates during wet granulation.
The source document describes an impeller driven through a gearbox and motor arrangement, with a separately driven chopper. Equipment operation and control are managed through a Programmable Logic Controller (PLC) and operator interface.
The actual equipment design, drive arrangement, control architecture, capacity and operating parameters should always be taken from the approved equipment specification and site-specific qualification documents.
Why Is RMG Performance Qualification Required?
An RMG can be mechanically functional and still fail to deliver consistent process performance. For example, inadequate mixing, inappropriate operating conditions, poor wet-mass formation or inefficient discharge may ultimately affect granule quality and downstream processing.
PQ therefore helps establish documented evidence that:
- The equipment performs consistently within the established operating range.
- Mixing performance is reproducible.
- Wet mass formation is appropriate for the intended process.
- The equipment can process the defined batch or challenge load without unacceptable interruptions.
- Relevant product characteristics are consistently achieved.
- Sampling from different locations does not reveal unacceptable variability.
- Equipment performance remains suitable for the intended manufacturing process.
WHO describes qualification as documented evidence that equipment is properly installed and/or operates correctly and produces the expected results.
Importance of RMG Qualification in Pharmaceutical Manufacturing
The RMG is directly involved in one of the critical stages of many oral solid dosage manufacturing processes. Variations in equipment performance can influence the quality and consistency of the wet granulation process.
A well-designed qualification programme helps the manufacturer establish confidence in:
- Equipment capability – whether the RMG can perform its intended function.
- Process reproducibility – whether similar operating conditions produce consistent results.
- Mixing performance – whether material is adequately mixed throughout the bowl.
- Wet mass formation – whether the wet mass is sufficiently uniform.
- Granule formation – whether the equipment produces the expected granulation behaviour.
- Discharge performance – whether processed material can be discharged effectively.
- Control-system performance – whether the PLC/HMI and associated instrumentation support the intended operation.
WHO GMP principles require pharmaceutical manufacturing processes and equipment to be appropriately controlled, documented and maintained in a state that supports consistent product quality.
Regulatory and GMP Expectations
Qualification should be performed as part of a structured qualification and validation programme rather than as an isolated activity.
Important GMP expectations include:
- Qualification should be based on an approved protocol.
- Responsibilities should be clearly defined.
- Acceptance criteria should be established before execution.
- Relevant equipment and process parameters should be identified.
- Results should be documented contemporaneously.
- Deviations should be investigated and appropriately documented.
- Changes affecting qualified status should be controlled through the site’s change control system.
- Qualification documentation should be reviewed and approved by appropriate functions.
- Continued qualification status should be maintained through an appropriate lifecycle programme.
WHO’s validation guidance states that qualification and validation should be performed according to predetermined protocols and appropriately documented in reports.
Important point about acceptance criteria
Acceptance criteria should not be copied from another company’s RMG protocol simply because the equipment has a similar name or capacity.
The criteria should be scientifically justified and based on applicable product requirements, process knowledge, equipment design, validated process parameters, risk assessment and approved site documentation.
Qualification Team and Responsibilities
A cross-functional team is generally appropriate because RMG performance involves equipment, manufacturing and quality considerations.
The source protocol identifies Quality Assurance, Formulation and Development, Quality Control and Engineering as participating functions.
Quality Assurance
Typical responsibilities include:
- Initiating and coordinating the qualification activity.
- Reviewing the PQ protocol.
- Ensuring that predefined requirements are followed.
- Coordinating with Engineering and other relevant departments.
- Reviewing the executed PQ documentation.
- Assessing deviations and changes.
- Approving the final qualification report.
The source document specifically assigns QA responsibilities for initiation, review, approval, compilation and post-execution review of the PQ documentation.
Quality Control
QC may provide analytical support for samples collected during qualification, particularly where product testing or mixing-uniformity assessment is required.
The source identifies QC responsibilities including protocol review, analytical support and review of completed documentation.
Engineering
Engineering generally provides technical support for the equipment and its associated systems, including troubleshooting during qualification.
The source assigns Engineering responsibility for coordination, execution and technical support for RMG PQ as well as troubleshooting and review of the completed qualification report.
Prerequisites Before Starting RMG PQ
Performance Qualification should not begin until the required prerequisites have been reviewed and found satisfactory.
The source protocol identifies document verification as a prerequisite and includes the following documents:
| Document / Record | Purpose |
|---|---|
| DQ Protocol and Report | Confirms documented design qualification |
| IQ Protocol and Report | Confirms installation qualification |
| OQ Protocol and Report | Confirms operational qualification |
| RMG Operation and Cleaning SOP | Defines routine operation and cleaning |
| RMG Preventive Maintenance SOP | Defines maintenance requirements |
These documents are listed in the source protocol as records to be verified before PQ execution.
Calibration status
Instruments used for qualification should have an appropriate calibration status before they are used for measurement or evaluation.
The source includes a calibration-status table covering instrument identification, purpose, calibration date, due date and verification by Engineering and QA.
Before execution, it is therefore useful to verify:
- Instrument identification.
- Current calibration status.
- Calibration due date.
- Equipment status.
- Availability of approved SOPs.
- Availability of approved qualification documents.
- Availability of required batch/product material.
- Availability of trained personnel.
Performance Qualification Approach
The uploaded protocol uses two broad performance-evaluation approaches:
- Evaluation using placebo formulation
- Evaluation using drug products
This approach allows equipment performance to be assessed before or alongside evaluation under actual product-processing conditions, depending on the approved qualification strategy.
The source describes placebo evaluation as a means of verifying equipment performance within the operational range and establishing performance-based operating conditions.
Performance Evaluation Using Placebo
Placebo evaluation may be used to challenge the equipment under predefined operating conditions without introducing an active pharmaceutical ingredient, where justified by the qualification strategy.
The source identifies several checks:
- Impeller ampere load with product.
- Chopper ampere load with product.
- Dry-mix appearance.
- Wet-mix appearance.
- Uniformity of wet mass.
- Granule formation.
- Presence or absence of dry powder lumps.
- Product discharge performance.
General procedure
A typical sequence based on the uploaded protocol is:
- Load the specified sifted material into the RMG bowl.
- Perform dry mixing using the approved process parameters.
- Visually examine the material during mixing.
- After the specified mixing time, collect samples from defined locations.
- Examine the samples for uniformity.
- Add the specified binder solution.
- Perform wet mixing for the predetermined time.
- Collect samples from defined locations.
- Examine the wet mass for consistency and uniformity.
- Check for unwanted dry powder lumps.
- Evaluate discharge performance.
The source follows this sequence for placebo evaluation.
Placebo acceptance criteria
The source states that all components should perform without problems or interruptions during processing of the complete batch.
For specific observations, the protocol identifies expectations such as:
| Parameter | Expected result in source protocol |
|---|---|
| Dry-mix appearance | Uniform |
| Wet-mix appearance | Uniform |
| Wet-mass uniformity | Uniform |
| Granule formation | Uniform |
| Dry powder lumps | Absent at sampling locations |
| Discharge | Efficient |
These criteria should be applied only as appropriate to the approved protocol and equipment/process design.
Performance Evaluation Using Drug Products
Drug-product evaluation provides evidence that the RMG performs consistently when processing the intended pharmaceutical formulation or an appropriately justified product challenge.
The source identifies the purpose as verifying performance within the established operating range and demonstrating consistent performance against predefined criteria.
Checks during drug-product evaluation
The source includes:
Dry mixing
- Appearance of the dry mix.
- Mixing uniformity.
Wet mixing
- Appearance of wet mass.
- Uniformity of cohesive wet mass.
- Granule formation.
- Presence of dry powder lumps.
- Discharge performance.
General procedure
The process described in the source can be organized as follows:
- Load the sifted raw materials into the RMG.
- Perform dry mixing according to the approved batch manufacturing record.
- Visually examine the powder during mixing.
- Collect samples from predetermined locations after the specified mixing period.
- Evaluate the samples for uniformity.
- Add binder solution as specified by the approved process.
- Perform wet mixing for the defined period.
- Collect samples from predetermined locations.
- Examine the samples for wet-mass consistency and dry powder lumps.
- Submit appropriate samples to QC for analytical evaluation.
The source specifically describes QC analysis of samples for mixing uniformity.
Acceptance Criteria for Mixing Uniformity
The uploaded protocol specifies the following criteria for its drug-product evaluation:
- Assay results from the defined sampling locations should comply with the applicable product specification.
- The RSD of individual assay values should not exceed 2.0%, according to the source protocol.
- Dry and wet masses should be uniform.
- No dry powder lump should be present in the evaluated wet-mass samples.
These criteria are reproduced here as source-specific criteria, not as a universal regulatory limit for every RMG or every pharmaceutical product. The approved site protocol and product-specific requirements should determine the final acceptance criteria.
Sampling Plan for RMG Performance Qualification
Sampling is one of the most important parts of an RMG performance study because poor sampling can hide or exaggerate variability.
The source protocol describes duplicate samples of approximately 10 g from nine locations using a sampling rod, with samples placed in separately identified bags.
Nine-location sampling approach
The source divides the RMG bowl into three levels:
| Level | Sampling points |
|---|---|
| Upper layer | U1, U2, U3 |
| Middle layer | M1, M2, M3 |
| Lower layer | L1, L2, L3 |
This gives a total of nine sampling locations. A composite sample is also identified in the source sampling arrangement.
This type of sampling is intended to assess whether material distribution is reasonably consistent throughout different regions of the bowl.
Mixing Uniformity Analysis
The qualification report should provide a clear record of analytical results from the defined sampling locations.
A useful presentation can include:
| Sampling Location | Batch 1 | Batch 2 | Batch 3 | Average | %RSD |
|---|---|---|---|---|---|
| U1 | Record result | Record result | Record result | Calculate | Calculate |
| U2 | Record result | Record result | Record result | Calculate | Calculate |
| U3 | Record result | Record result | Record result | Calculate | Calculate |
| M1 | Record result | Record result | Record result | Calculate | Calculate |
| M2 | Record result | Record result | Record result | Calculate | Calculate |
| M3 | Record result | Record result | Record result | Calculate | Calculate |
| L1 | Record result | Record result | Record result | Calculate | Calculate |
| L2 | Record result | Record result | Record result | Calculate | Calculate |
| L3 | Record result | Record result | Record result | Calculate | Calculate |
The uploaded protocol includes a results table for three batches and the nine sampling locations, followed by average, composite and %RSD fields.
The source specifies an RSD criterion of not more than 2.0% for individual assay results at different sampling locations. Again, this should be treated as the criterion established by the supplied protocol rather than a universal GMP requirement.
PLC and HMI Considerations
Modern RMGs may use PLC-based controls to manage equipment operation and display process information.
The source describes the PLC as collecting information from field instruments and making it available through the operator interface. The HMI allows the operator to supervise the process and issue commands to the control system.
Where a computerized control system is part of the equipment, its qualification and computerized-system controls should be addressed according to the site’s approved validation strategy.
The source also mentions password protection for different user levels, including administrator, manager, supervisor and operator access.
Deviations During Performance Qualification
A deviation should not simply be corrected and ignored.
Any departure from the approved protocol, predefined acceptance criterion or expected qualification condition should be documented and evaluated according to the site’s deviation procedure.
The source requires deviations or modifications associated with PQ to be recorded.
A deviation record may include:
| Field | Information |
|---|---|
| Deviation No. | Unique identification |
| Requirement | Original requirement |
| Deviation | Description of actual event |
| Immediate action | Action taken at the time |
| Impact assessment | Potential effect on qualification |
| Investigation | Root-cause assessment where required |
| Corrective action | Approved action |
| QA review | Quality assessment and approval |
Requalification of RMG
The source identifies several circumstances under which RMG requalification may become applicable:
- Replacement of parts that directly affect equipment performance.
- Major repair or modification.
- Transfer of the RMG to another location within the premises.
- Product/process trend showing variation potentially associated with equipment operation.
- Periodic qualification.
These are the circumstances listed in the supplied protocol.
In practice, the need and extent of requalification should be determined through the site’s approved validation programme and documented impact/risk assessment.
Common Mistakes During RMG PQ
Several practical issues can weaken the value of an RMG qualification study.
1. Starting PQ before prerequisites are complete
PQ should not be treated as a substitute for incomplete DQ, IQ or OQ documentation.
2. Using uncalibrated instruments
Measurement results are difficult to defend if instruments were not within their approved calibration status.
3. Using undefined sampling locations
Sampling locations should be predetermined and clearly identified.
4. Changing parameters during execution without documentation
Changing mixing time, impeller speed, chopper speed or other critical conditions without approved justification can compromise the study.
5. Ignoring deviations
A deviation should be documented and evaluated rather than silently corrected.
6. Using copied acceptance criteria
Acceptance criteria should be scientifically justified and linked to the equipment, process and product rather than copied from another qualification document.
7. Poor sample identification
Each sample should be traceable to the batch, sampling location, stage and applicable test.
8. Inadequate QA involvement
QA involvement is important for protocol approval, review of deviations and final assessment of qualification results.
Documentation and Records
A complete RMG PQ package may contain:
- Approved PQ protocol.
- Qualification team details.
- Equipment identification.
- Prerequisite checklist.
- DQ/IQ/OQ references.
- Calibration-status records.
- Batch/product details.
- Approved process parameters.
- Sampling plan.
- Raw observations.
- Analytical results.
- Mixing-uniformity results.
- Deviations.
- Change controls.
- Corrective actions.
- Summary and conclusion.
- Final approval.
- PQ report.
The source includes sections for post-execution summary, conclusion and recommendation, followed by post-approval signatures from the relevant departments.
Practical RMG Performance Qualification Checklist
| Checkpoint | Status |
|---|---|
| DQ completed and available | ☐ |
| IQ completed and available | ☐ |
| OQ completed and available | ☐ |
| Operation and cleaning SOP approved | ☐ |
| Preventive maintenance SOP available | ☐ |
| Instruments calibrated | ☐ |
| Equipment identification verified | ☐ |
| Required batch/material available | ☐ |
| PQ protocol approved | ☐ |
| Sampling plan approved | ☐ |
| Operating parameters defined | ☐ |
| Placebo evaluation completed, where applicable | ☐ |
| Drug-product evaluation completed, where applicable | ☐ |
| Analytical results reviewed | ☐ |
| Deviations assessed | ☐ |
| Change controls assessed | ☐ |
| Final conclusion documented | ☐ |
| PQ report approved | ☐ |
Conclusion
Rapid Mixer Granulator Performance Qualification provides documented evidence that the equipment can perform its intended function consistently under defined operating and process conditions.
An effective PQ programme should connect equipment capability with actual manufacturing requirements. It should begin with appropriate prerequisites, use predetermined operating and sampling conditions, evaluate relevant performance characteristics, and conclude with documented assessment of the results.
The most important principle is that the qualification should be scientifically justified, risk-based, reproducible and supported by complete documentation. PQ is not simply a collection of completed forms; it is evidence that the equipment remains capable of supporting the intended pharmaceutical process.
WHO guidance supports a lifecycle approach in which qualification and validation are planned, documented and maintained rather than treated as one-time exercises.
FAQs of RMG Performance Qualification
What is RMG Performance Qualification?
RMG Performance Qualification is a documented study demonstrating that a Rapid Mixer Granulator performs consistently and reproducibly within predefined operating and process conditions.
Is PQ performed before IQ and OQ?
Normally, qualification follows a logical sequence in which installation and operational qualification are completed before performance qualification. WHO describes qualification as preceding validation and recognizes equipment qualification as part of the broader validation lifecycle.
What parameters are commonly evaluated during RMG PQ?
Depending on the equipment and process, evaluation may include mixing performance, impeller and chopper load, dry-mix uniformity, wet-mass uniformity, granule formation, sampling-location variability and discharge performance.
How many sampling locations are used in the supplied RMG protocol?
The supplied protocol describes nine locations: U1, U2, U3, M1, M2, M3, L1, L2 and L3, representing upper, middle and lower regions of the RMG bowl.
Is an RSD limit of 2.0% a universal GMP requirement?
No. The supplied protocol specifies an RSD of not more than 2.0% for the relevant assay results. This should not automatically be treated as a universal regulatory limit. Acceptance criteria should be justified and approved for the particular product and qualification study.
When should an RMG be requalified?
Requalification may be required after changes or repairs that can affect performance, relocation, significant performance-related trends, or according to the site’s periodic qualification programme. The exact extent should be determined through documented assessment.